{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T05:27:07Z","timestamp":1788413227527,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100015739","name":"Bayer Vital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015739","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1007\/s00392-023-02283-4","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T07:02:22Z","timestamp":1692774142000},"page":"1848-1859","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Detection of atrial fibrillation using an implantable loop recorder in patients with previous cryptogenic stroke: the SPIDER-AF registry (Stroke Prevention by Increasing DEtection Rates of Atrial Fibrillation)"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1954-9688","authenticated-orcid":false,"given":"Karin","family":"Rybak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"D\u00b4Ancona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Gl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winfried","family":"Haerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franz","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the SPIDER-AF Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,23]]},"reference":[{"issue":"5","key":"2283_CR1","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan GA, Dilaveris PE, Fauchier L, Filippatos G, Kalman JM, La Meir M, Lane DA, Lebeau JP, Lettino M, Lip GYH, Pinto FJ, Thomas GN, Valgimigli M, Van Gelder IC, Van Putte BP, Watkins CL, ESC Scientific Document Group (2021) ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42(5):373\u2013498","journal-title":"Eur Heart J"},{"key":"2283_CR2","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB et al (2014) Embolic stroke of undetermined source: the case for a new clinical construct. Lancet Neurol 13:429\u2013438","journal-title":"Lancet Neurol"},{"key":"2283_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1161\/01.STR.19.5.547","volume":"19","author":"MA Foulkes","year":"1988","unstructured":"Foulkes MA et al (1988) The Stroke Data Bank: design, methods, and baseline characteristics. Stroke 19:547\u2013554","journal-title":"Stroke"},{"key":"2283_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappele EJ et al (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST Stroke 24:35\u201341","journal-title":"TOAST Stroke"},{"key":"2283_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.10644","volume":"54","author":"OY Bang","year":"2003","unstructured":"Bang OY, Lee PH, Joo SY et al (2003) Frequency of stroke recurrence after cryptogenic stroke. Ann Neurol 54:227\u2013234","journal-title":"Ann Neurol"},{"issue":"23","key":"2283_CR6","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart RG, Sharma M, Mundl H et al (2018) NAVIGATE ESUS Investigators. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 378(23):2191\u20132201","journal-title":"N Engl J Med"},{"key":"2283_CR7","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1056\/NEJMoa1813959","volume":"380","author":"HC Diener","year":"2019","unstructured":"Diener HC, Sacco RL, Easton JD et al (2019) Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med 380:1906\u20131917","journal-title":"N Engl J Med"},{"key":"2283_CR8","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/europace\/eup097","volume":"11","author":"M Brignole","year":"2009","unstructured":"Brignole M, Vardas P, Hoffmann e, et al (2009) Indications for the use of diagnostic implantable and external ECG loop recorders. Europace 11:671\u2013687","journal-title":"Europace"},{"key":"2283_CR9","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1056\/NEJMoa1311376","volume":"370","author":"DJ Gladstone","year":"2014","unstructured":"Gladstone DJ, Spring M, Dorian P et al (2014) Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med 370:2467\u20132477","journal-title":"N Engl J Med"},{"key":"2283_CR10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1161\/CIRCULATIONAHA.104.518837","volume":"112","author":"G Hindricks","year":"2005","unstructured":"Hindricks G, Piorkowski C, Tanner H et al (2005) Perception of atrial fibrillation bevor and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 112:307\u2013313","journal-title":"Circulation"},{"key":"2283_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.cjca.2013.03.023","volume":"29","author":"TV Glotzer","year":"2013","unstructured":"Glotzer TV, Ziegler PD (2013) Silent atrial fibrillation as a stroke risk factor and anticoagulation indication. Can J Cardiol 29:14\u201323","journal-title":"Can J Cardiol"},{"key":"2283_CR12","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1161\/STROKEAHA.111.676189","volume":"44","author":"MA Ritter","year":"2013","unstructured":"Ritter MA, Kochhauser S, Duning T et al (2013) Occult atrial fibrillation in cryptogenic stroke: detection by 7-day electrocardiogram versus implantable cardiac monitors. Stroke 44:1449\u20131452","journal-title":"Stroke"},{"key":"2283_CR13","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1056\/NEJMoa1313600","volume":"370","author":"T Sanna","year":"2014","unstructured":"Sanna T, Diener HC, Passman RS et al (2014) Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med 370:2478\u20132486","journal-title":"N Engl J Med"},{"key":"2283_CR14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/ene.12843","volume":"23","author":"S Poli","year":"2016","unstructured":"Poli S, Diedler J, Hartig F et al (2016) Insertable cardiac monitors after cryptogenic stroke\u2014a risk for based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol 23:375\u2013381","journal-title":"Eur J Neurol"},{"key":"2283_CR15","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.115.003333","volume":"9","author":"J Brachmann","year":"2016","unstructured":"Brachmann J, Morillo CA, Sanna T et al (2016) Uncovering atrial fibrillation beyond short-term monitoring in cryptogenic stroke patients: three-year results from the cryptogenic stroke and underlying atrial fibrillation trial. Circ Arrhythm Electrophysiol 9:e003333","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2283_CR16","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1055\/s-0043-118476","volume":"45","author":"KG H\u00e4usler","year":"2018","unstructured":"H\u00e4usler KG, Gr\u00f6schel K, K\u00f6hrmann M et al (2018) Positionspapier zur Detektion von Vorhofflimmern nach isch\u00e4mischem Schlaganfall. Aktuelle Neurol 45:93\u2013106","journal-title":"Aktuelle Neurol"},{"key":"2283_CR17","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ijcard.2017.06.039","volume":"244","author":"P Ziegler","year":"2017","unstructured":"Ziegler P, Rogers J, Ferreira S et al (2017) Long-term detection of atrial fibrillation with insertable cardiac monitors in a real-world cryptogenic stroke population. Int J Cardiol 244:175\u2013179","journal-title":"Int J Cardiol"},{"key":"2283_CR18","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1161\/STROKEAHA.113.001340","volume":"44","author":"T Etgen","year":"2013","unstructured":"Etgen T, Hochreiter M, Mundel M et al (2013) Insertable cardiac event recorder in detection of atrial fibrillation after cryptogenic stroke. Stroke 44:2007\u20132013","journal-title":"Stroke"},{"key":"2283_CR19","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/pace.12688","volume":"38","author":"MR Afzal","year":"2015","unstructured":"Afzal MR, Gunda S, Waheed S et al (2015) Role of outpatient cardiac rhythm monitoring in cryptogenic stroke: a systematic review and meta-analysis. Pacing Clin Electrophys 38:1236\u20131245","journal-title":"Pacing Clin Electrophys"},{"key":"2283_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCEP.114.002521","volume":"8","author":"C Dussault","year":"2015","unstructured":"Dussault C, Toeg H, Nathan M et al (2015) Electrocardiografic monitoring for detecting atrial fibrillation after ischemic stroke or transient ischemic attack: systematic review and meta-analysis. Circ Arrhythm Electrophysiol 8:263\u2013269","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"1","key":"2283_CR21","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ahj.2010.03.032","volume":"160","author":"AM Sinha","year":"2010","unstructured":"Sinha AM, Diener HC, Morillo CA et al (2010) Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): design and rationale. Am Heart J 160(1):36\u201341","journal-title":"Am Heart J"},{"key":"2283_CR22","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1161\/STROKEAHA.119.025169","volume":"50","author":"G Tsivgoulis","year":"2019","unstructured":"Tsivgoulis G, Katsanos A, Grory B et al (2019) Prolonged cardiac rhythm monitoring and secondary stroke prevention in patients with cryptogenic cerebral ischemia. Stroke 50:2175\u20132218","journal-title":"Stroke"},{"key":"2283_CR23","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"D Kleindorfer","year":"2021","unstructured":"Kleindorfer D, Towfighi A, Chaturvedi S et al (2021) Guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association\/American Stroke Association. Stroke 52:e364\u2013e467","journal-title":"Stroke"},{"key":"2283_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10840-010-9485-5","volume":"28","author":"F Dion","year":"2010","unstructured":"Dion F, Saudeau D, Bonnaud I et al (2010) Unexpected low prevalence of atrial fibrillation in cryptogenic ischemic stroke: a prospective study. J Interv Card Electrophysiol 28:101\u2013107","journal-title":"J Interv Card Electrophysiol"},{"issue":"4","key":"2283_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/anec.12319","volume":"21","author":"K Dahal","year":"2016","unstructured":"Dahal K, Chapagain B, Maharjan R et al (2016) Prolonged cardiac monitoring to detect atrial fibrillation after cryptogenic stroke or transient ischemic attack: a meta-analysis of randomized controlled trials. Ann Noninvasive Electrocardiol 21(4):382\u2013388","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"2283_CR26","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1161\/01.CIR.89.1.224","volume":"89","author":"RL Page","year":"1994","unstructured":"Page RL, Wilkinson WE, Clair WK et al (1994) Asymptomatic arrhythmias in patients with symptomatic paroxysmal atrial fibrillation and paroxysmal supraventricular tachycardia. Circulation 89:224\u2013227","journal-title":"Circulation"},{"key":"2283_CR27","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1161\/CIRCEP.109.849638","volume":"2","author":"TV Glotzer","year":"2009","unstructured":"Glotzer TV, Daoud E, Wyse G et al (2009) The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk. Circ Arrhythm Electrophysiol 2:474\u2013480","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2283_CR28","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa1105575","volume":"366","author":"JS Healey","year":"2012","unstructured":"Healey JS, Connolly SJ, Gold MR et al (2012) Subclinical atrial fibrillation and the risk of stroke. N Engl J Med 366:120\u2013129","journal-title":"N Engl J Med"},{"key":"2283_CR29","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/eurheartj\/ehx042","volume":"38","author":"IC Van Gelder","year":"2017","unstructured":"Van Gelder IC, Healey JS, Crijns HJGM (2017) Duration of device-detected subclinical atrial fibrillation and occurrence of stroke in ASSERT. Eur Heart J 38:1339\u20131344","journal-title":"Eur Heart J"},{"key":"2283_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R et al (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro Heart Survey on atrial fibrillation. Chest 137:263\u2013272","journal-title":"Chest"},{"key":"2283_CR31","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1161\/CIRCULATIONAHA.113.007825","volume":"129","author":"M Brambatti","year":"2014","unstructured":"Brambatti M, Connolly SJ, Gold MR et al (2014) Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 129:2094\u20132099","journal-title":"Circulation"},{"key":"2283_CR32","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/ijs.12555","volume":"10","author":"LA Sposato","year":"2015","unstructured":"Sposato LA, Cipriano LE, Riccio PM et al (2015) Very short paroxysm account for more than half of the cases of atrial fibrillation detected after stroke and TIA: a systematic review and meta-analysis. Int J Stroke 10:801\u2013807","journal-title":"Int J Stroke"},{"issue":"10310","key":"2283_CR33","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","volume":"398","author":"JH Svendsen","year":"2021","unstructured":"Svendsen JH, Diederichsen SZ, Hojberg S et al (2021) Implantable loop recorder detection of atrial fibrillation to prevent stroke (the LOOP study): a randomised controlled trial. Lancet 398(10310):1507\u20131516","journal-title":"Lancet"},{"issue":"10310","key":"2283_CR34","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","volume":"398","author":"E Svennberg","year":"2021","unstructured":"Svennberg E, Friberg L, Frykman V et al (2021) Clinical outcomes in systematic screening for atrial fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial. Lancet 398(10310):1498\u20131506","journal-title":"Lancet"},{"key":"2283_CR35","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","volume":"383","author":"CT Ruff","year":"2014","unstructured":"Ruff CT, Giugliano RP, Braunwald E et al (2014) Comparison of the efficacy and safety of new oral anticoagulants with Warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet 383:955\u2013962","journal-title":"Lancet"},{"key":"2283_CR36","doi-asserted-by":"crossref","unstructured":"Haas S, Camm JA, Harald D et al (2023) GARFIELD-AF: risk profiles, treatment patterns and 2-year outcomes in patients with atrial fibrillation in Germany, Austria and Switzerland (DACH) compared to 32 countries in other regions worldwide. Clin Res Cardiol 112:759\u2013771","DOI":"10.1007\/s00392-022-02079-y"},{"issue":"9","key":"2283_CR37","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/1747493016681019","volume":"12","author":"T Geisler","year":"2017","unstructured":"Geisler T, Poli S, Meisner C et al (2017) Apixaban for treatment of embolic stroke of undetermined source (ATTICUS randomized trial): rationale and study design. Int J Stroke 12(9):985\u2013990","journal-title":"Int J Stroke"},{"issue":"2","key":"2283_CR38","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1177\/1747493018799981","volume":"14","author":"H Kamel","year":"2019","unstructured":"Kamel H, Longstreth WT Jr, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY et al (2019) The atrial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke 14(2):207\u2013214","journal-title":"Int J Stroke"},{"issue":"4","key":"2283_CR39","doi-asserted-by":"publisher","first-page":"e288","DOI":"10.1212\/WNL.0000000000006748","volume":"92","author":"S Jalini","year":"2019","unstructured":"Jalini S, Rajalingam R, Nisenbaum R et al (2019) Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology 92(4):e288\u2013e294","journal-title":"Neurology"},{"key":"2283_CR40","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1161\/STROKEAHA.115.008714","volume":"46","author":"DJ Gladstone","year":"2015","unstructured":"Gladstone DJ, Dorian P, Spring M et al (2015) Atrial premature beats predict atrial fibrillation in cryptogenic stroke: results from the embrace trial. Stroke 46:936\u2013941","journal-title":"Stroke"},{"key":"2283_CR41","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","volume":"121","author":"Z Bicini","year":"2010","unstructured":"Bicini Z, Intzilakis T, Nielsen OW et al (2010) Excessive supraventricular ectopic activity an increased risk of atrial fibrillation and stroke. Circulation 121:1904\u20131911","journal-title":"Circulation"},{"key":"2283_CR42","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1161\/CIR.0000000000000757","volume":"141","author":"SS Virani","year":"2020","unstructured":"Virani SS, Alonso A, Benjamin EJ (2020) Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation 141:e139\u2013e596","journal-title":"Circulation"},{"key":"2283_CR43","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.119.041303","volume":"140","author":"RM Kaplan","year":"2019","unstructured":"Kaplan RM, Koehler J, Ziegler PD et al (2019) Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc-Score. Circulation 140:1639\u20131646","journal-title":"Circulation"},{"key":"2283_CR44","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1212\/WNL.0000000000002282","volume":"86","author":"VN Thijs","year":"2016","unstructured":"Thijs VN, Brachmann J, Morillo CA et al (2016) Predictors for atrial fibrillation detection after cryptogenic stroke: results from crystal AF. Neurology 86:261\u2013269","journal-title":"Neurology"},{"issue":"4","key":"2283_CR45","doi-asserted-by":"publisher","first-page":"e34351","DOI":"10.1371\/journal.pone.0034351","volume":"7","author":"R Wachter","year":"2012","unstructured":"Wachter R, Lahno R, Haase B et al (2012) Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia: the FIND-AF study. PLoS ONE 7(4):e34351","journal-title":"PLoS ONE"},{"key":"2283_CR46","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/CIRCULATIONAHA.109.882241","volume":"121","author":"RB Schnabel","year":"2010","unstructured":"Schnabel RB, Larson MG, Yamamoto JF et al (2010) Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community. Circulation 121:200\u2013207","journal-title":"Circulation"},{"issue":"15","key":"2283_CR47","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016040","volume":"9","author":"M Riordan","year":"2020","unstructured":"Riordan M, Opaskar A, Yoruk A et al (2020) Predictors of atrial fibrillation during long-term implantable cardiac monitoring following cryptogenic stroke. J Am Heart Assoc 9(15):e016040","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2283_CR48","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/S1474-4422(17)30002-9","volume":"16","author":"R Wachter","year":"2017","unstructured":"Wachter R, Groschel K, Gelbrich G et al (2017) Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF RANDOMISED): an open-label randomised controlled trial. Lancet Neurol 16(4):282\u2013290","journal-title":"Lancet Neurol"},{"key":"2283_CR49","doi-asserted-by":"crossref","unstructured":"Haeusler KG, Kirchhof P, Kunze C et al (2021) Systematic monitoring for detection of atrial fibrillation in patients with acute ischemic stroke (MonDAFIS): a randomised, open label, multicentre study. Lancet Neurol 20(6):426\u2013436","DOI":"10.1016\/S1474-4422(21)00067-3"},{"issue":"4","key":"2283_CR50","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1161\/CIRCRESAHA.121.319915","volume":"130","author":"KM Rexrode","year":"2022","unstructured":"Rexrode KM, Madsen TE, Yu AYX et al (2022) The impact of sex and gender on stroke. Circ Res 130(4):512\u2013528","journal-title":"Circ Res"},{"key":"2283_CR51","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1161\/STROKEAHA.117.018418","volume":"49","author":"TE Madsen","year":"2018","unstructured":"Madsen TE, Howard VJ, Jim\u00e9nez M et al (2018) Impact of conventional stroke risk factors on stroke in women: an update. Stroke 49:536\u2013542","journal-title":"Stroke"},{"key":"2283_CR52","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/clc.23284","volume":"43","author":"A Kostopoulou","year":"2020","unstructured":"Kostopoulou A, Zeljko HM, Bogossian H, on the behalf of the DAS-CAM participants-2017\u20132018 et al (2020) Atrial fibrillation-related stroke in women: evidence and inequalities in epidemiology, mechanisms, clinical presentation, and management. Clin Cardiol 43:14\u201323. https:\/\/doi.org\/10.1002\/clc.23284","journal-title":"Clin Cardiol"},{"key":"2283_CR53","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.1161\/STROKEAHA.115.011979","volume":"47","author":"JH Yong","year":"2016","unstructured":"Yong JH, Thavorn K, Hoch JS et al (2016) Potential cost-effectiveness of ambulatory cardiac rhythm monitoring after cryptogenic stroke. Stroke 47:2380\u20132385","journal-title":"Stroke"},{"key":"2283_CR54","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1177\/1747493015620803","volume":"11","author":"A Diamatopoulos","year":"2013","unstructured":"Diamatopoulos A, Sawyer LM, Lip GY et al (2013) Cost-effectiveness of an insertable cardiac monitor to detect atrial fibrillation in patients with cryptogenic stroke. Int J Stroke 11:302\u2013312","journal-title":"Int J Stroke"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02283-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02283-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02283-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T16:57:44Z","timestamp":1701795464000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02283-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,23]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["2283"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02283-4","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,23]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Medtronic and Bayer Vital GmbH have sponsored the study. KR, SG, WH, and FG have received honorary fees for conducting the study. There are no further conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}